The Food and Drug Administration plans to greenlight updated versions of the COVID-19 booster as early as Friday, according to four people familiar with the agency’s plans.
The latest shots are designed to target the XBB.1.5 omicron subvariant. Though this particular strain is no longer dominant, the boosters should still provide protection against current circulating subvariants, which are closely related, the drugmakers and experts say.
The Friday timeline for authorization is not firm and could slide into early next week, two of the sources said. That could prompt further criticism from some doctors who say that federal health agencies are acting too slowly in the booster rollout as COVID cases and hospitalizations are once again rising.Sign up for NBC San Diego newsletters.
Two sources who spoke to NBC News indicated the FDA is exploring the possibility of granting the boosters a full approval license instead of an emergency use authorization, a departure from the approach used for previous Covid vaccine authorizations. However, it remains uncertain whether this is still the intended course of action.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA could green light new Covid boosters as early as FridayThe shots could become available next week, after the Centers for Disease Control and Prevention also signs off.
Leer más »
Weight loss product sold on Amazon, Walmart could be fatal, FDA saysThe FDA announced Todorganic Inc. is recalling Nuez de la India seeds because they appear to actually be yellow oleander seeds, which are toxic.
Leer más »
Vyvanse Generics Approved by FDAThe FDA approval of generic versions of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets will likely ease cost and accessibility barriers to prescription stimulants for ADHD.
Leer más »
Over-the-counter sales of Narcan to begin this weekThe nasal spray is the first FDA approved over-the-counter medicine to reverse opioid overdose.
Leer más »
Heart Medication Recalled After Dangerous Label Mix-Up, FDA WarnsMarlex Pharmaceuticals, Inc. voluntarily recalled two lots of Digoxin heart medication after the labels were mixed up.
Leer más »
All The Ways COVID Can Affect Your Heart, According To DoctorsSevere COVID-19 infections and long COVID both can wreak havoc on your cardiovascular system.
Leer más »